Investigating the safety and efficacy of hematopoietic and mesenchymal stem cell transplantation for treatment of T1DM: a systematic review and meta-analysis.

Syst Rev · 2022 · PMC9059401 · PMID 35501872

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Although our total and subgroups meta-analysis showed a trend of SCT efficacy from 3 to 12 months after the transplantation, these trends were not statistically significant except for the adjusted HbA1c.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.